7 medicines held by Esteve Pharmaceuticals S.A. on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Caprelsa 100 mg film-coated tablets EU/1/11/749/001 |
Vandetanib | Esteve Pharmaceuticals S.A. | — |
| Caprelsa 300 mg film-coated tablets EU/1/11/749/002 |
Vandetanib | Esteve Pharmaceuticals S.A. | — |
| Increlex 10 mg/ml solution for injection EU/1/07/402/001 |
Mecasermin | Esteve Pharmaceuticals S.A. | — |
| Ketoconazole Esteve 200 mg tablets EU/1/14/965/001 |
Ketoconazole | Esteve Pharmaceuticals S.A. | — |
| Lysodren 500mg tablets EU/1/04/273/001 |
Mitotane | Esteve Pharmaceuticals S.A. | — |
| Mepact 4 mg Powder for concentrate for dispersion for infusion EU/1/08/502/001 |
Mifamurtide | Esteve Pharmaceuticals S.A. | — |
| Metopirone 250 mg soft capsules PA23005/001/001 |
Metyrapone | Esteve Pharmaceuticals S.A. | Marketed |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 14 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.